Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GeneDx Holdings Corp (Class A) | Keith A. Meister | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.35 per share. | 17 Apr 2023 | 22,336,624 | 120,141,890 | - | 0.3 | 7,817,818 | Class A Common Stock |
| Bakkt Holdings Inc (Class A) | Gavin Michael | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 520,500 | 3,063,914 | - | 0 | Class A Common Stock | |
| Apollo Global (Class A) (New) | Joshua J. Harris | See Remarks | Sale of securities on an exchange or to another person at price $ 65.43 per share. | 17 Apr 2023 | 399,146 | 36,355,055 (15%) | 0% | 65.4 | 26,116,123 | Common Stock |
| Bakkt Holdings Inc (Class A) | Gavin Michael | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. | 17 Apr 2023 | 287,838 | 2,867,213 | - | 1.5 | 423,122 | Class A Common Stock |
| Apollo Global (Class A) (New) | Joshua J. Harris | See Remarks | Sale of securities on an exchange or to another person at price $ 65.09 per share. | 17 Apr 2023 | 286,157 | 36,754,201 (15%) | 0% | 65.1 | 18,625,959 | Common Stock |
| Oramed Pharma Inc | Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 279,000 | 1,332,098 (7%) | 1% | - | Common Stock | |
| Ribbon Communications Inc | Bruce W. McClelland | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 232,342 | 232,342 | - | - | Performance-Based RSUs (PSUs) | |
| Oramed Pharma Inc | Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 213,000 | 414,666 (2%) | 1% | - | Common Stock | |
| Ribbon Communications Inc | Bruce W. McClelland | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 206,526 | 206,526 | - | - | Restricted Stock Units (RSUs) | |
| Outlook Therapeutics Inc | Jeff Evanson | Chief Commercial Officer | 17 Apr 2023 | 192,143 | 192,143 | - | - | Stock Option (Right to Buy) | ||
| Outlook Therapeutics Inc | Terry Dagnon | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 192,143 | 192,143 | - | - | Stock Option (Right to Buy) | |
| Apollo Global (Class A) (New) | Joshua J. Harris | See Remarks | Sale of securities on an exchange or to another person at price $ 65.64 per share. | 17 Apr 2023 | 186,137 | 36,168,064 (15%) | 0% | 65.6 | 12,218,033 | Common Stock |
| Viking Therapeutics Inc | Brian Lian | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 20.45 per share. | 17 Apr 2023 | 155,000 | 2,277,963 (3%) | 0% | 20.5 | 3,169,766 | Common Stock, par value $0.00001 per share |
| Ribbon Communications Inc | Miguel A. Lopez | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 154,895 | 154,895 | - | - | RSUs | |
| Ribbon Communications Inc | Sam Bucci | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 154,895 | 154,895 | - | - | RSUs | |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| nLIGHT Inc | Scott H. Keeney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 150,000 | 1,231,343 (3%) | 0% | 0 | Common Stock | |
| Danaher | Steven M. Rales | Director, Chairman | 17 Apr 2023 | 125,437 | 4,355,808 (0%) | 0% | 199.3 | 24,999,594 | Common Stock, par value $.01 | |
| Viking Therapeutics Inc | Brian Lian | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 125,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Brian Lian | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.15 per share. | 17 Apr 2023 | 125,000 | 2,432,963 (3%) | 0% | 2.2 | 268,750 | Common Stock, par value $0.00001 per share |
| Ribbon Communications Inc | Patrick W. Macken | EVP, CLO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 123,916 | 123,916 | - | - | RSUs | |
| Ribbon Communications Inc | Bruce W. McClelland | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 123,915 | 123,915 | - | - | PSUs | |
| Ribbon Communications Inc | Dan Redington | EVP, Global Sales | 17 Apr 2023 | 108,426 | 108,426 | - | - | Restricted Stock Units (RSUs) | ||
| Oramed Pharma Inc | Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 108,000 | 274,333 (1%) | 0% | - | Common Stock | |
| SES AI Corp (Class A) | Rohit Makharia | PRES. & CHIEF OP. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 104,603 | 104,603 | - | 0 | Class A Common Stock | |
| SES AI Corp (Class A) | Rohit Makharia | PRES. & CHIEF OP. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 104,603 | 104,603 | - | - | Performance Vesting Restricted Stock Units | |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 100,000 | 100,000 (0%) | 0% | 0 | Common Stock | |
| Oramed Pharma Inc | David Silberman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 97,500 | 205,500 (1%) | 0% | - | Common Stock | |
| Ribbon Communications Inc | Miguel A. Lopez | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 92,937 | 92,937 | - | - | PSUs | |
| Ribbon Communications Inc | Eric Marmurek | SVP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 92,937 | 92,937 | - | - | RSUs | |
| Ribbon Communications Inc | Sam Bucci | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 92,937 | 92,937 | - | - | PSUs | |
| Bakkt Holdings Inc (Class A) | Gavin Michael | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 91,137 | 3,155,051 | - | 0 | Class A Common Stock | |
| Ribbon Communications Inc | Bruce W. McClelland | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 82,611 | 82,611 | - | - | PSUs | |
| InnovAge Holding Corp | Christine Bent | CHIEF OPERATIONS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 82,143 | 82,143 | - | 0 | Common Stock, $0.001 par value | |
| Xponential Fitness Inc (Class A) | Anthony Geisler | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.83 per share. | 17 Apr 2023 | 81,570 | 443,479 | - | 32.8 | 2,677,943 | Class A Common Stock |
| Oramed Pharma Inc | Netanel Derovan | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 81,000 | 129,000 (0%) | 0% | - | Common Stock | |
| Ribbon Communications Inc | Patrick W. Macken | EVP, CLO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 74,349 | 74,349 | - | - | PSUs | |
| Ribbon Communications Inc | Dan Redington | EVP, Global Sales | 17 Apr 2023 | 65,055 | 65,055 | - | - | PSUs | ||
| Ribbon Communications Inc | Miguel A. Lopez | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 61,958 | 61,958 | - | - | PSUs | |
| Ribbon Communications Inc | Sam Bucci | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 61,958 | 61,958 | - | - | PSUs | |
| Ribbon Communications Inc | Miguel A. Lopez | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 60,990 | 60,990 | - | - | Performance-Based RSUs (PSUs) | |
| Ribbon Communications Inc | Miguel A. Lopez | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 60,990 | 60,990 | - | - | PSUs | |
| Energous Corp | Sheryl Wilkerson | Director | Sale of securities on an exchange or to another person at price $ 0.43 per share. | 17 Apr 2023 | 60,473 | 36,487 (0%) | 0% | 0.4 | 26,251 | Common Stock |
| PTC Therapeutics Inc | Mark E. Boulding | EXEC. VP AND CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 58,631 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Mark E. Boulding | EXEC. VP AND CLO | Sale of securities on an exchange or to another person at price $ 51.42 per share. | 17 Apr 2023 | 58,631 | 75,378 (0%) | 0% | 51.4 | 3,014,554 | Common Stock |
| PTC Therapeutics Inc | Mark E. Boulding | EXEC. VP AND CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.86 per share. | 17 Apr 2023 | 58,631 | 134,009 (0%) | 0% | 30.9 | 1,809,353 | Common Stock |
| Xponential Fitness Inc (Class A) | Anthony Geisler | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.52 per share. | 17 Apr 2023 | 57,100 | 525,049 | - | 32.5 | 1,856,892 | Class A Common Stock |
| Amplify Energy Corp | James G. Frew | SVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 55,829 | 55,829 | - | - | Performance Stock Units | |
| Amplify Energy Corp | James G. Frew | SVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 55,829 | 55,829 | - | - | Restricted Stock Units | |
| Ribbon Communications Inc | Eric Marmurek | SVP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 55,762 | 55,762 | - | - | Performance-Based RSUs (PSUs) | |
| Faraday Future Intelligent Electric Inc (Class A) | Li Han | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 54,011 | 0 | - | - | Restricted Stock Units | |
| Faraday Future Intelligent Electric Inc (Class A) | Li Han | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 54,011 | 54,011 | - | - | Class A Common Stock | |
| Faraday Future Intelligent Electric Inc (Class A) | Li Han | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 54,011 | 54,011 | - | - | Restricted Stock Units | |
| Ribbon Communications Inc | Miguel A. Lopez | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 53,420 | 106,836 | - | - | Restricted Stock Units (RSUs) | |
| Ribbon Communications Inc | Miguel A. Lopez | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 53,420 | 226,381 (0%) | 0% | - | Common Stock | |
| Ribbon Communications Inc | Sam Bucci | EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 53,420 | 233,022 (0%) | 0% | 0 | Common Stock | |
| Ribbon Communications Inc | Sam Bucci | EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 53,420 | 106,836 | - | - | Restricted Stock Units (RSUs) | |
| Xponential Fitness Inc (Class A) | Anthony Geisler | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.15 per share. | 17 Apr 2023 | 51,104 | 582,149 | - | 32.2 | 1,642,994 | Class A Common Stock |
| Ribbon Communications Inc | Patrick W. Macken | EVP, CLO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 50,534 | 50,534 | - | - | Performance-Based RSUs (PSUs) | |
| Bakkt Holdings Inc (Class A) | Gavin Michael | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. | 17 Apr 2023 | 50,400 | 2,816,813 | - | 1.5 | 74,088 | Class A Common Stock |
| Danaher | Mitchell P. Rales | Director, Chairman of Exec. Committee | 17 Apr 2023 | 50,175 | 912,654 (0%) | 0% | 199.3 | 9,999,878 | Common Stock, par value $.01 | |
| Bakkt Holdings Inc (Class A) | Marc D’Annunzio | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 50,000 | 783,320 | - | 0 | Class A Common Stock | |
| nLIGHT Inc | Joseph Corso | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 50,000 | 198,208 (0%) | 0% | 0 | Common Stock | |
| Sunrun Inc | Edward Fenster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. | 17 Apr 2023 | 50,000 | 1,317,994 (1%) | 0% | 5 | 250,000 | Common Stock |
| Sunrun Inc | Edward Fenster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 50,000 | 279,000 | - | - | Employee Stock Option (right to buy) | |
| Sunrun Inc | Edward Fenster | Director | Sale of securities on an exchange or to another person at price $ 19.97 per share. | 17 Apr 2023 | 50,000 | 1,267,994 (1%) | 0% | 20.0 | 998,695 | Common Stock |
| Ribbon Communications Inc | Patrick W. Macken | EVP, CLO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 49,567 | 49,567 | - | - | PSUs | |
| Ribbon Communications Inc | Sam Bucci | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 49,464 | 49,464 | - | - | Performance-Based RSUs (PSUs) | |
| Amylyx Pharma Inc | Patrick Yeramian | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.53 per share. | 17 Apr 2023 | 49,279 | 208,717 | - | 30.5 | 1,504,660 | Common Stock |
| Ribbon Communications Inc | Dan Redington | EVP, Global Sales | 17 Apr 2023 | 47,049 | 47,049 | - | - | Performance-Based RSUs (PSUs) | ||
| Amylyx Pharma Inc | Patrick Yeramian | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 44,861 | 17,605 | - | - | Stock Option (right to buy) | |
| Amylyx Pharma Inc | Patrick Yeramian | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.37 per share. | 17 Apr 2023 | 44,861 | 253,278 | - | 0.4 | 16,599 | Common Stock |
| Ribbon Communications Inc | Dan Redington | EVP, Global Sales | 17 Apr 2023 | 43,371 | 43,371 | - | - | PSUs | ||
| Ribbon Communications Inc | Patrick W. Macken | EVP, CLO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 42,736 | 85,469 | - | - | Restricted Stock Units (RSUs) | |
| Ribbon Communications Inc | Patrick W. Macken | EVP, CLO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 42,736 | 166,691 (0%) | 0% | 0 | Common Stock | |
| UiPath Inc (Class A) | Ashim Gupta | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.18 per share. | 17 Apr 2023 | 40,000 | 1,624,341 | - | 16.2 | 647,184 | Class A Common Stock |
| Zumiez Inc | Troy R. Brown | President North America | Sale of securities on an exchange or to another person at price $ 18.55 per share. | 17 Apr 2023 | 40,000 | 31,735 (0%) | 0% | 18.6 | 742,000 | Common Stock |
| Ribbon Communications Inc | Eric Marmurek | SVP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 37,175 | 37,175 | - | - | PSUs | |
| Codexis Inc | John J. Nicols | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 35,714 | 178,570 | - | - | Stock Option (Right to Buy) | |
| Codexis Inc | John J. Nicols | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 35,714 | 142,856 | - | - | Stock Option (Right to Buy) | |
| Codexis Inc | John J. Nicols | Director | Sale of securities on an exchange or to another person at price $ 4.24 per share. | 17 Apr 2023 | 35,714 | 783,965 (1%) | 0% | 4.2 | 151,377 | Common Stock |
| Codexis Inc | John J. Nicols | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.97 per share. | 17 Apr 2023 | 35,714 | 819,679 (1%) | 0% | 2.0 | 70,357 | Common Stock |
| Codexis Inc | John J. Nicols | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.97 per share. | 17 Apr 2023 | 35,714 | 819,679 (1%) | 0% | 2.0 | 70,357 | Common Stock |
| Codexis Inc | John J. Nicols | Director | Sale of securities on an exchange or to another person at price $ 4.14 per share. | 17 Apr 2023 | 35,714 | 783,965 (1%) | 0% | 4.1 | 147,874 | Common Stock |
| Public Service Enterprise | Daniel J. Cregg | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 63.70 per share. | 17 Apr 2023 | 31,398 | 163,007 (0%) | 0% | 63.7 | 2,000,053 | Common Stock |
| ProFrac Holding Corp (Class A) | Phillip Blaine Wilbanks | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 30,219 | 109,404 | - | 0 | Class A common stock, par value $0.01 per share | |
| AMKOR Tech Inc | Guillaume Marie Jean Rutten | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 23.92 per share. | 17 Apr 2023 | 30,000 | 119,808 (0%) | 0% | 23.9 | 717,600 | Common Stock |
| Oramed Pharma Inc | Leonard Sank | Director | 17 Apr 2023 | 30,000 | 58,696 (0%) | 0% | - | Common Stock | ||
| Oramed Pharma Inc | Arie Mayer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 30,000 | 56,809 (0%) | 0% | - | Common Stock | |
| Oramed Pharma Inc | Yadin Rozov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 30,000 | 116,500 (0%) | 0% | - | Common Stock | |
| Ribbon Communications Inc | Sam Bucci | EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.74 per share. | 17 Apr 2023 | 28,595 | 204,427 (0%) | 0% | 2.7 | 78,350 | Common Stock |
| Arista Networks | Anshul Sadana | SVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 162.85 per share. | 17 Apr 2023 | 27,372 | 80,446 (0%) | 0% | 162.9 | 4,457,634 | Common Stock |
| Ribbon Communications Inc | Eric Marmurek | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 26,710 | 193,021 (0%) | 0% | 0 | Common Stock | |
| Ribbon Communications Inc | Eric Marmurek | SVP, Finance & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 26,710 | 53,418 | - | - | Restricted Stock Units (RSUs) | |
| Revelation Biosciences Inc | George F. Tidmarsh | Director | 17 Apr 2023 | 26,500 | 39,848 | - | 1.2 | 30,740 | Common Stock | |
| Riot Platforms Inc | Lance D'Ambrosio | Director | Sale of securities on an exchange or to another person at price $ 12.51 per share. | 17 Apr 2023 | 26,000 | 43,441 (0%) | 0% | 12.5 | 325,260 | Common Stock |
| Agilon Health Inc | Benjamin Shaker | Chief Markets Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 25,000 | 51,851 | - | - | Options (Right to buy) | |
| Agilon Health Inc | Benjamin Shaker | Chief Markets Officer | Sale of securities on an exchange or to another person at price $ 28.05 per share. | 17 Apr 2023 | 25,000 | 79,543 | - | 28.0 | 701,130 | Common Stock |
| Agilon Health Inc | Benjamin Shaker | Chief Markets Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.00 per share. | 17 Apr 2023 | 25,000 | 104,543 | - | 3 | 75,000 | Common Stock |
| Energy Vault Holdings Inc | Andrea Pedretti | Chief Technology Officer | 17 Apr 2023 | 25,000 | 2,173,216 | - | 1.8 | 44,290 | Common Stock | |
| Revelation Biosciences Inc | George F. Tidmarsh | Director | 17 Apr 2023 | 25,000 | 64,848 | - | 1.2 | 29,000 | Common Stock | |
| Danaher | Steven M. Rales | Director, Chairman | 17 Apr 2023 | 25,000 | 0 | - | - | Series B Mandatory Convertible Preferred Stock | ||
| Bakkt Holdings Inc (Class A) | Karen Alexander | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 24,999 | 410,879 | - | 0 | Class A Common Stock | |
| Agilon Health Inc | Benjamin Shaker | Chief Markets Officer | Sale of securities on an exchange or to another person at price $ 27.70 per share. | 17 Apr 2023 | 23,600 | 80,943 | - | 27.7 | 653,640 | Common Stock |
| Trimble | Robert G. Painter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 23,405 | 46,812 | - | - | Restricted Stock Unit | |
| Trimble | Robert G. Painter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.78 per share. | 17 Apr 2023 | 23,405 | 174,157 (0%) | 0% | 49.8 | 1,165,101 | Common Stock |
| Agilon Health Inc | Benjamin Shaker | Chief Markets Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 23,149 | 76,851 | - | - | Options (Right to buy) | |
| Agilon Health Inc | Benjamin Shaker | Chief Markets Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.00 per share. | 17 Apr 2023 | 23,149 | 104,543 | - | 3 | 69,447 | Common Stock |
| Stitch Fix Inc (Class A) | Sarah Barkema | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 22,921 | 88,824 (0%) | 0% | 0 | Class A Common Stock | |
| Brandywine Realty Trust | Gerard H. Sweeney | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.05 per share. | 17 Apr 2023 | 22,515 | 1,847,153 (1%) | 0% | 4.1 | 91,186 | Common Shares of Beneficial Ownership |
| Dell | Brunilda Rios | Chief Accounting Officer | 17 Apr 2023 | 22,042 | 18,647 (0%) | 0% | 43.8 | 964,999 | Class C Common Stock | |
| Bakkt Holdings Inc (Class A) | Marc D’Annunzio | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 21,873 | 805,193 | - | 0 | Class A Common Stock | |
| TCW Strategic Income Fund Inc | Laird Landmann | PORTFOLIO MANAGER | Sale of securities on an exchange or to another person at price $ 4.70 per share. | 17 Apr 2023 | 21,139 | 105,444 (0%) | 0% | 4.7 | 99,406 | Common Stock |
| Viking Therapeutics Inc | Lawson Macartney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 20,786 | 0 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Lawson Macartney | Director | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 17 Apr 2023 | 20,786 | 47,965 (0%) | 0% | 20 | 415,720 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Lawson Macartney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.00 per share. | 17 Apr 2023 | 20,786 | 68,751 (0%) | 0% | 8 | 166,288 | Common Stock, par value $0.00001 per share |
| Ribbon Communications Inc | Miguel A. Lopez | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.74 per share. | 17 Apr 2023 | 20,272 | 206,109 (0%) | 0% | 2.7 | 55,545 | Common Stock |
| Arista Networks | Anshul Sadana | SVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 18,443 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Arista Networks | Anshul Sadana | SVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.67 per share. | 17 Apr 2023 | 18,443 | 99,486 (0%) | 0% | 7.7 | 141,412 | Common Stock |
| Ribbon Communications Inc | Patrick W. Macken | EVP, CLO & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.74 per share. | 17 Apr 2023 | 18,038 | 148,653 (0%) | 0% | 2.7 | 49,424 | Common Stock |
| Super League Enterprise Inc | David Steigelfest | Director, CHIEF PLATFORM OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.42 per share. | 17 Apr 2023 | 17,817 | 138,935 (1%) | 0% | 0.4 | 7,483 | Common Stock |
| Pulse Biosciences Inc | Mitchell E. Levinson | Director, Chief Strategy Officer | 17 Apr 2023 | 17,700 | 17,700 | - | - | Stock Option (right to buy) | ||
| PTC | Blake D. Moret | Director | Sale of securities on an exchange or to another person at price $ 128.42 per share. | 17 Apr 2023 | 16,629 | 6,939,103 (6%) | 0% | 128.4 | 2,135,440 | Common Stock |
| Super League Enterprise Inc | Clayton J. Haynes | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.42 per share. | 17 Apr 2023 | 15,547 | 81,267 (0%) | 0% | 0.4 | 6,530 | Common Stock |
| Bakkt Holdings Inc (Class A) | Marc D’Annunzio | General Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. | 17 Apr 2023 | 15,051 | 790,142 | - | 1.5 | 22,125 | Class A Common Stock |
| Capricor Therapeutics Inc | Xavier Avat | Former CBO | Sale of securities on an exchange or to another person at price $ 64258.00 per share. | 17 Apr 2023 | 14,772 | 0 (0%) | 0% | 64258 | 949,219,176 | Common Stock |
| Opendoor Tech Inc | Christina Schwartz | See Remarks | Sale of securities on an exchange or to another person at price $ 1.68 per share. | 17 Apr 2023 | 14,532 | 757,227 | - | 1.7 | 24,375 | Common Stock |
| Lakeland Ind Inc | Charles D. Roberson | Director, CEO, President and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 14,491 | 86,089 (1%) | 0% | 0 | Common Stock, par value $.01 per share | |
| InnovAge Holding Corp | Patricia Fontneau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 14,286 | 14,286 | - | 0 | Common Stock, $0.001 par value | |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.18 per share. | 17 Apr 2023 | 13,263 | 79,035 (0%) | 0% | 18.2 | 241,121 | Common Stock |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 38.47 per share. | 17 Apr 2023 | 13,263 | 65,772 (0%) | 0% | 38.5 | 510,228 | Common Stock |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 13,263 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Rambus Inc | Luc Seraphin | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 49.58 per share. | 17 Apr 2023 | 12,500 | 292,153 (0%) | 0% | 49.6 | 619,714 | Common Stock |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.07 per share. | 17 Apr 2023 | 12,500 | 300,263 (0%) | 0% | 13.1 | 163,375 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 12,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 17 Apr 2023 | 12,500 | 287,763 (0%) | 0% | 20 | 250,000 | Common Stock, par value $0.00001 per share |
| UiPath Inc (Class A) | Ashim Gupta | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.18 per share. | 17 Apr 2023 | 12,000 | 231,505 | - | 16.2 | 194,160 | Class A Common Stock |
| Transocean Ltd | David A. Tonnel | SVP - CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 6.53 per share. | 17 Apr 2023 | 12,000 | 476,802 (0%) | 0% | 6.5 | 78,360 | Registered Shares |
| Boston Scientific | Wendy Carruthers | EVP, Human Resources | 17 Apr 2023 | 11,671 | 83,373 (0%) | 0% | 52.0 | 606,423 | Common Stock | |
| PTC Therapeutics Inc | David P. Southwell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 11,429 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | David P. Southwell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 17 Apr 2023 | 11,429 | 21,929 (0%) | 0% | 18.0 | 205,836 | Common Stock |
| First Business Fin Services Inc | Corey A. Chambas | Director, CEO | Grant, award, or other acquisition of securities at price $ 29.13 per share. | 17 Apr 2023 | 11,400 | 147,922 (1%) | 0% | 29.1 | 332,082 | Common Stock |
| Fastly Inc (Class A) | Artur Bergman | Director, Chief Architect | Sale of securities on an exchange or to another person at price $ 15.79 per share. | 17 Apr 2023 | 11,163 | 6,541,523 (9%) | 0% | 15.8 | 176,264 | Class A Common Stock |
| DigitalOcean Holdings Inc | Christopher Merritt | Director | 17 Apr 2023 | 10,995 | 10,995 | - | 0 | Common Stock | ||
| Ionis Pharma Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 10,838 | 14,451 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 10,838 | 47,261 | - | - | Restricted Stock Unit | |
| Crocs Inc | Andrew Rees | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 140.41 per share. | 17 Apr 2023 | 10,836 | 99,748 (0%) | 0% | 140.4 | 1,521,472 | Common Stock |
| Coursera Inc | Leah F. Belsky | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 10.90 per share. | 17 Apr 2023 | 10,834 | 1,246,039 | - | 10.9 | 118,108 | Common Stock |
| Coursera Inc | Leah F. Belsky | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 10,834 | 137,332 | - | - | Stock Option (right to buy) | |
| Coursera Inc | Leah F. Belsky | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.91 per share. | 17 Apr 2023 | 10,834 | 1,256,873 | - | 7.9 | 85,697 | Common Stock |
| Trimble | Robert G. Painter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.78 per share. | 17 Apr 2023 | 10,240 | 163,917 (0%) | 0% | 49.8 | 509,747 | Common Stock |
| AMKOR Tech Inc | Guillaume Marie Jean Rutten | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 10,000 | 102,500 | - | - | Employee Stock Option (Right-to-Buy) | |
| AMKOR Tech Inc | Guillaume Marie Jean Rutten | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.17 per share. | 17 Apr 2023 | 10,000 | 149,808 (0%) | 0% | 14.2 | 141,700 | Common Stock |
| Iradimed Corp | Roger Susi | Director, President, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 39.69 per share. | 17 Apr 2023 | 10,000 | 522,950 (4%) | 0% | 39.7 | 396,925 | Common Stock |
| Vertex Inc (Class A) | Lisa Butler | CHIEF ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 10,000 | 60,946 | - | - | Stock Option | |
| Vertex Inc (Class A) | Lisa Butler | CHIEF ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 17 Apr 2023 | 10,000 | 10,250 | - | 2.5 | 25,000 | Class A Common Stock |
| Vertex Inc (Class A) | Lisa Butler | CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 22.45 per share. | 17 Apr 2023 | 10,000 | 250 | - | 22.4 | 224,480 | Class A Common Stock |
| XPEL Inc - Ordinary Shares - Reg S | Richard K. Crumly | Director | Sale of securities on an exchange or to another person at price $ 70.85 per share. | 17 Apr 2023 | 10,000 | 573,768 (2%) | 0% | 70.9 | 708,500 | Common Stock |
| XPEL Inc - Ordinary Shares - Reg S | Richard K. Crumly | Director | Sale of securities on an exchange or to another person at price $ 72.62 per share. | 17 Apr 2023 | 10,000 | 583,768 (2%) | 0% | 72.6 | 726,200 | Common Stock |
| Danaher | Mitchell P. Rales | Director, Chairman of Exec. Committee | 17 Apr 2023 | 10,000 | 0 | - | - | Series B Mandatory Convertible Preferred Stock | ||
| Perdoceo Education Corporation | John R. Kline | SVP, AIU | Sale of securities on an exchange or to another person at price $ 13.43 per share. | 17 Apr 2023 | 10,000 | 168,315 (0%) | 0% | 13.4 | 134,300 | Common Stock |
| Ribbon Communications Inc | Bruns H. Grayson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 9,869 | 415,263 (0%) | 0% | - | Common Stock | |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 88.41 per share. | 17 Apr 2023 | 9,724 | 1,709,838 (9%) | 0% | 88.4 | 859,662 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 88.41 per share. | 17 Apr 2023 | 9,724 | 1,652,763 (9%) | 0% | 88.4 | 859,662 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 88.41 per share. | 17 Apr 2023 | 9,724 | 1,714,188 (9%) | 0% | 88.4 | 859,662 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 88.41 per share. | 17 Apr 2023 | 9,724 | 1,649,706 (9%) | 0% | 88.4 | 859,662 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 87.41 per share. | 17 Apr 2023 | 9,429 | 1,662,487 (9%) | 0% | 87.4 | 824,202 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 87.41 per share. | 17 Apr 2023 | 9,429 | 1,659,430 (9%) | 0% | 87.4 | 824,202 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 87.41 per share. | 17 Apr 2023 | 9,428 | 1,719,562 (9%) | 0% | 87.4 | 824,114 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 87.41 per share. | 17 Apr 2023 | 9,428 | 1,723,912 (9%) | 0% | 87.4 | 824,114 | Common Stock |
| nLIGHT Inc | James Nias | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 9,334 | 52,156 (0%) | 0% | 0 | Common Stock | |
| TCW Strategic Income Fund Inc | Laird Landmann | PORTFOLIO MANAGER | Sale of securities on an exchange or to another person at price $ 4.70 per share. | 17 Apr 2023 | 9,329 | 96,115 (0%) | 0% | 4.7 | 43,855 | Common Stock |
| Five9 Inc | Barry Zwarenstein | Chief Financial Officer | 17 Apr 2023 | 9,249 | 98,054 (0%) | 0% | 71.2 | 658,529 | Common Stock | |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.84 per share. | 17 Apr 2023 | 9,183 | 74,955 (0%) | 0% | 23.8 | 218,923 | Common Stock |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 38.47 per share. | 17 Apr 2023 | 9,183 | 65,772 (0%) | 0% | 38.5 | 353,270 | Common Stock |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 9,183 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Crocs Inc | Andrew Rees | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 140.02 per share. | 17 Apr 2023 | 9,164 | 110,584 (0%) | 0% | 140.0 | 1,283,111 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 8,500 | 6,458 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 17 Apr 2023 | 8,500 | 174,325 (0%) | 0% | 1.7 | 14,285 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 13.97 per share. | 17 Apr 2023 | 8,500 | 165,825 (0%) | 0% | 14.0 | 118,728 | Common Stock |
| Lantheus Holdings Inc | Paul M. Blanchfield | See Remarks | 17 Apr 2023 | 8,464 | 95,028 (0%) | 0% | 0 | Common Stock | ||
| Brandywine Realty Trust | George D. Johnstone | EVP, Operations | 17 Apr 2023 | 8,385 | 317,812 (0%) | 0% | 4.0 | 33,959 | Common Shares of Beneficial Interest | |
| Brandywine Realty Trust | Thomas E. Wirth | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.05 per share. | 17 Apr 2023 | 8,175 | 368,799 (0%) | 0% | 4.1 | 33,109 | Common Shares of Beneficial Interest |
| FactSet Research | Goran Skoko | EVP, Research & Advisory | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 7,969 | 0 | - | - | Employee Stock Option (right to buy) | |
| FactSet Research | Goran Skoko | EVP, Research & Advisory | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.20 per share. | 17 Apr 2023 | 7,969 | 12,321 (0%) | 0% | 175.2 | 1,396,169 | Common Stock |
| Lakeland Ind Inc | Christopher J. Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 7,802 | 125,915 (1%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Viking Therapeutics Inc | Greg S. Zante | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.07 per share. | 17 Apr 2023 | 7,500 | 156,779 (0%) | 0% | 13.1 | 98,025 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Greg S. Zante | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 7,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Greg S. Zante | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 17 Apr 2023 | 7,500 | 149,279 (0%) | 0% | 20 | 150,000 | Common Stock, par value $0.00001 per share |
| Apollo Global (Class A) (New) | Joshua J. Harris | See Remarks | Sale of securities on an exchange or to another person at price $ 65.99 per share. | 17 Apr 2023 | 7,400 | 36,160,664 (15%) | 0% | 66.0 | 488,326 | Common Stock |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.28 per share. | 17 Apr 2023 | 7,373 | 60,941 (0%) | 0% | 26.3 | 193,762 | Common Stock |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 38.97 per share. | 17 Apr 2023 | 7,373 | 53,568 (0%) | 0% | 39.0 | 287,326 | Common Stock |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 7,373 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Trimble | David G. Barnes | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 7,314 | 14,629 | - | - | Restricted Stock Unit | |
| Trimble | David G. Barnes | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.78 per share. | 17 Apr 2023 | 7,314 | 37,135 (0%) | 0% | 49.8 | 364,091 | Common Stock |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.32 per share. | 17 Apr 2023 | 7,222 | 60,790 (0%) | 0% | 28.3 | 204,527 | Common Stock |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 38.97 per share. | 17 Apr 2023 | 7,222 | 65,772 (0%) | 0% | 39.0 | 281,441 | Common Stock |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 7,222 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| AbbVie | Elaine K. Sorg | SVP, US COMMERCIAL OPERATIONS | Sale of securities on an exchange or to another person at price $ 161.64 per share. | 17 Apr 2023 | 6,999 | 35,830 (0%) | 0% | 161.6 | 1,131,318 | Common Stock, $0.01 par value |
| Arcturus Therapeutics Holdings Inc | Keith C. Kummerfeld | See Remarks | Sale of securities on an exchange or to another person at price $ 28.18 per share. | 17 Apr 2023 | 6,968 | 950 (0%) | 0% | 28.2 | 196,358 | Common Stock |
| Arista Networks | Anshul Sadana | SVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 163.57 per share. | 17 Apr 2023 | 6,948 | 73,498 (0%) | 0% | 163.6 | 1,136,512 | Common Stock |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.28 per share. | 17 Apr 2023 | 6,764 | 72,536 (0%) | 0% | 26.3 | 177,758 | Common Stock |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 38.47 per share. | 17 Apr 2023 | 6,764 | 65,772 (0%) | 0% | 38.5 | 260,211 | Common Stock |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 6,764 | 7,373 | - | - | Employee Stock Option (Right to Buy) | |
| Jacobs Solutions | Steven J. Demetriou | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 115.24 per share. | 17 Apr 2023 | 6,666 | 607,956 (0%) | 0% | 115.2 | 768,190 | Common Stock |
| Bakkt Holdings Inc (Class A) | Marc D’Annunzio | General Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. | 17 Apr 2023 | 6,585 | 783,557 | - | 1.5 | 9,680 | Class A Common Stock |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.32 per share. | 17 Apr 2023 | 6,528 | 72,300 (0%) | 0% | 28.3 | 184,873 | Common Stock |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 38.47 per share. | 17 Apr 2023 | 6,528 | 65,772 (0%) | 0% | 38.5 | 251,132 | Common Stock |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 6,528 | 7,222 | - | - | Employee Stock Option (Right to Buy) | |
| Ribbon Communications Inc | Eric Marmurek | SVP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.74 per share. | 17 Apr 2023 | 6,503 | 186,518 (0%) | 0% | 2.7 | 17,818 | Common Stock |
| Transdigm Group | Walter Nicholas Howley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 173.29 per share. | 17 Apr 2023 | 6,500 | 28,047 (0%) | 0% | 173.3 | 1,126,385 | Common Stock |
| Transdigm Group | Walter Nicholas Howley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 6,500 | 117,190 | - | - | Stock Option | |
| Lakeland Ind Inc | Charles D. Roberson | Director, CEO, President and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.55 per share. | 17 Apr 2023 | 6,362 | 79,727 (0%) | 0% | 12.5 | 79,843 | Common Stock, par value $.01 per share |
| PTC Therapeutics Inc | David P. Southwell | Director | Sale of securities on an exchange or to another person at price $ 50.69 per share. | 17 Apr 2023 | 6,241 | 15,688 (0%) | 0% | 50.7 | 316,348 | Common Stock |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 39.22 per share. | 17 Apr 2023 | 6,102 | 59,670 (0%) | 0% | 39.2 | 239,320 | Common Stock |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 38.93 per share. | 17 Apr 2023 | 6,102 | 53,568 (0%) | 0% | 38.9 | 237,551 | Common Stock |
| Coursera Inc | Leah F. Belsky | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 10.90 per share. | 17 Apr 2023 | 5,834 | 1,240,205 | - | 10.9 | 63,608 | Common Stock |
| Brandywine Realty Trust | H. Jeffrey Devuono | EVP & Senior Managing Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.05 per share. | 17 Apr 2023 | 5,681 | 328,767 (0%) | 0% | 4.0 | 23,008 | Common Shares of Beneficial Interest |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 5,675 | 43,190 | - | - | ResMed Common Stock Options | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 224.23 per share. | 17 Apr 2023 | 5,675 | 436,900 (0%) | 0% | 224.2 | 1,272,526 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 17 Apr 2023 | 5,675 | 442,575 (0%) | 0% | 57.8 | 327,788 | ResMed Common Stock |
| Ionis Pharma Inc | Onaiza Cadoret-Manier | EVP, Chf GL Pdt Str & Oper Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 5,667 | 49,659 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Onaiza Cadoret-Manier | EVP, Chf GL Pdt Str & Oper Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 5,667 | 26,894 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharma Inc | William J. Peters | Director, CFO, EVP & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 5,632 | 28,990 | - | - | Employee Stock Option (right to buy) | |
| Amphastar Pharma Inc | William J. Peters | Director, CFO, EVP & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.35 per share. | 17 Apr 2023 | 5,632 | 110,780 (0%) | 0% | 13.3 | 75,187 | Common Stock |
| Amphastar Pharma Inc | William J. Peters | Director, CFO, EVP & Treasurer | Sale of securities on an exchange or to another person at price $ 42.35 per share. | 17 Apr 2023 | 5,632 | 105,148 (0%) | 0% | 42.3 | 238,515 | Common Stock |
| Snap Inc (Class A) | Rebecca Morrow | CAO | Sale of securities on an exchange or to another person at price $ 10.69 per share. | 17 Apr 2023 | 5,617 | 252,497 (0%) | 0% | 10.7 | 60,031 | Class A Common Stock |
| FactSet Research | Goran Skoko | EVP, Research & Advisory | Sale of securities on an exchange or to another person at price $ 412.66 per share. | 17 Apr 2023 | 5,569 | 6,752 (0%) | 0% | 412.7 | 2,298,104 | Common Stock |
| Lakeland Ind Inc | An Hui | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 5,543 | 36,225 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| First Business Fin Services Inc | David R. Seiler | President and COO | Grant, award, or other acquisition of securities at price $ 29.13 per share. | 17 Apr 2023 | 5,280 | 26,574 (0%) | 0% | 29.1 | 153,806 | Common Stock |
| Palo Alto | Arora Nikesh | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 201.53 per share. | 17 Apr 2023 | 5,211 | 1,181,546 (1%) | 0% | 201.5 | 1,050,178 | Common Stock |
| PTC Therapeutics Inc | David P. Southwell | Director | Sale of securities on an exchange or to another person at price $ 51.43 per share. | 17 Apr 2023 | 5,188 | 10,500 (0%) | 0% | 51.4 | 266,840 | Common Stock |
| Arista Networks | Anshul Sadana | SVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 5,168 | 32,668 | - | - | Non-Qualified Stock Option (right to buy) | |
| Arista Networks | Anshul Sadana | SVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.58 per share. | 17 Apr 2023 | 5,168 | 107,818 (0%) | 0% | 56.6 | 292,431 | Common Stock |
| Lantheus Holdings Inc | Paul M. Blanchfield | See Remarks | 17 Apr 2023 | 5,025 | 5,025 | - | - | Stock Option (right to buy) | ||
| Delta Air Lines | Glen W. Hauenstein | President | Sale of securities on an exchange or to another person at price $ 34.53 per share. | 17 Apr 2023 | 5,000 | 273,712 (0%) | 0% | 34.5 | 172,650 | Common Stock |
| AMKOR Tech Inc | Guillaume Marie Jean Rutten | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 5,000 | 10,265 | - | - | Employee Stock Option (Right-to-Buy) | |
| AMKOR Tech Inc | Guillaume Marie Jean Rutten | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.48 per share. | 17 Apr 2023 | 5,000 | 139,808 (0%) | 0% | 9.5 | 47,400 | Common Stock |
| ON Semiconductor | Hassane El-Khoury | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 77.10 per share. | 17 Apr 2023 | 5,000 | 601,312 (0%) | 0% | 77.1 | 385,500 | Common |
| Amylyx Pharma Inc | Patrick Yeramian | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 4,718 | 43,534 | - | - | Stock Option (right to buy) | |
| Amylyx Pharma Inc | Patrick Yeramian | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.88 per share. | 17 Apr 2023 | 4,718 | 257,996 | - | 6.9 | 32,460 | Common Stock |
| Funko Inc (Class A) | Brian Mariotti | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 4,688 | 0 | - | - | Restricted Stock Units | |
| Funko Inc (Class A) | Brian Mariotti | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 4,688 | 111,636 (0%) | 0% | 0 | CLASS A COMMON STOCK | |
| First Business Fin Services Inc | Corey A. Chambas | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.13 per share. | 17 Apr 2023 | 4,525 | 143,397 (1%) | 0% | 29.1 | 131,813 | Common Stock |
| Arcturus Therapeutics Holdings Inc | Keith C. Kummerfeld | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 4,500 | 25,500 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Holdings Inc | Keith C. Kummerfeld | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.04 per share. | 17 Apr 2023 | 4,500 | 6,481 (0%) | 0% | 9.0 | 40,680 | Common Stock |
| Lakeland Ind Inc | Alfred John Kreft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 4,458 | 58,967 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Lakeland Ind Inc | Jeffrey T. Schlarbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 4,458 | 17,657 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Lakeland Ind Inc | James M. Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 4,458 | 19,838 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Palo Alto | Arora Nikesh | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 202.35 per share. | 17 Apr 2023 | 4,353 | 1,177,193 (1%) | 0% | 202.3 | 880,808 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 86.80 per share. | 17 Apr 2023 | 4,298 | 1,728,990 (9%) | 0% | 86.8 | 373,051 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 86.80 per share. | 17 Apr 2023 | 4,298 | 1,733,340 (10%) | 0% | 86.8 | 373,051 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 86.80 per share. | 17 Apr 2023 | 4,297 | 1,671,916 (9%) | 0% | 86.8 | 372,964 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 86.80 per share. | 17 Apr 2023 | 4,297 | 1,668,859 (9%) | 0% | 86.8 | 372,964 | Common Stock |
| PNC Financial | Deborah Guild | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.09 per share. | 17 Apr 2023 | 4,286 | 18,601 (0%) | 0% | 125.1 | 536,136 | $5 Par Common Stock |
| Lakeland Ind Inc | Thomas J. McAteer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 4,264 | 51,326 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Brandywine Realty Trust | William D. Redd | EVP & Senior Managing Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.05 per share. | 17 Apr 2023 | 4,245 | 218,316 (0%) | 0% | 4.0 | 17,192 | Common Shares of Beneficial Interest |
| Palo Alto | Arora Nikesh | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 200.35 per share. | 17 Apr 2023 | 4,236 | 1,186,757 (1%) | 0% | 200.3 | 848,666 | Common Stock |
| Riot Platforms Inc | Lance D'Ambrosio | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Apr 2023 | 4,000 | 39,441 (0%) | 0% | 0 | Common Stock | |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 17 Apr 2023 | 3,961 | 171,325 | - | 18.0 | 71,316 | Common Stock |
| Xponential Fitness Inc (Class A) | Anthony Geisler | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Apr 2023 | 3,920 | 10,702 | - | 0 | Class B Common Stock | |
| Xponential Fitness Inc (Class A) | Anthony Geisler | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Apr 2023 | 3,920 | 10,702 | - | - | LLC Units in Xponential Holdings LLC | |
| Ionis Pharma Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 36.50 per share. | 17 Apr 2023 | 3,880 | 10,571 (0%) | 0% | 36.5 | 141,631 | Common Stock |
| LCI Ind | Lillian D. Etzkorn | EVP CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 3,818 | 3,818 | - | - | Performance Stock Unit | |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 166.23 per share. | 17 Apr 2023 | 3,792 | 441,586 (0%) | 0% | 166.2 | 630,349 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 166.23 per share. | 17 Apr 2023 | 3,791 | 446,109 (0%) | 0% | 166.2 | 630,183 | Class A Common Stock |
| Yum Brands | Tracy L. Skeans | COO and CPO | Sale of securities on an exchange or to another person at price $ 136.00 per share. | 17 Apr 2023 | 3,680 | 3,183 (0%) | 0% | 136 | 500,480 | Common Stock |
| CIENA Corp | David M. Rothenstein | SVP and Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 50.77 per share. | 17 Apr 2023 | 3,500 | 244,475 (0%) | 0% | 50.8 | 177,695 | Common Stock |
| Legacy Housing Corp | Douglas M Shipley | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 21.68 per share. | 17 Apr 2023 | 3,479 | 3,030,056 (12%) | 0% | 21.7 | 75,425 | Common Stock, par value $0.001 per share ("Common Stock") |
| Opendoor Tech Inc | Christina Schwartz | See Remarks | Sale of securities on an exchange or to another person at price $ 1.66 per share. | 17 Apr 2023 | 3,456 | 753,771 | - | 1.7 | 5,729 | Common Stock |
| Boston Scientific | Wendy Carruthers | EVP, Human Resources | 17 Apr 2023 | 3,448 | 27,586 | - | - | Stock Option (Right to Buy) | ||
| Boston Scientific | Wendy Carruthers | EVP, Human Resources | 17 Apr 2023 | 3,448 | 92,084 (0%) | 0% | 16.3 | 56,237 | Common Stock | |
| Trimble | Darryl R. Matthews | SVP & Sector Head | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.78 per share. | 17 Apr 2023 | 3,413 | 44,135 (0%) | 0% | 49.8 | 169,899 | Common Stock |
| Trimble | Darryl R. Matthews | SVP & Sector Head | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 3,413 | 6,828 | - | - | Restricted Stock Unit | |
| Trimble | Ronald J. Bisio | Sr. Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.78 per share. | 17 Apr 2023 | 3,413 | 64,125 (0%) | 0% | 49.8 | 169,899 | Common Stock |
| Trimble | Ronald J. Bisio | Sr. Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 3,413 | 6,828 | - | - | Restricted Stock Unit | |
| PTC | Blake D. Moret | Director | Sale of securities on an exchange or to another person at price $ 129.02 per share. | 17 Apr 2023 | 3,371 | 6,935,732 (6%) | 0% | 129.0 | 434,925 | Common Stock |
| Lantheus Holdings Inc | Daniel M. Niedzwiecki | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 3,301 | 78,171 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Mark E. Boulding | EXEC. VP AND CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 3,292 | 58,631 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Mark E. Boulding | EXEC. VP AND CLO | Sale of securities on an exchange or to another person at price $ 51.42 per share. | 17 Apr 2023 | 3,292 | 75,378 (0%) | 0% | 51.4 | 169,276 | Common Stock |
| PTC Therapeutics Inc | Mark E. Boulding | EXEC. VP AND CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.86 per share. | 17 Apr 2023 | 3,292 | 78,670 (0%) | 0% | 30.9 | 101,591 | Common Stock |
| First Business Fin Services Inc | Bradley A. Quade | Chief Credit Officer | Grant, award, or other acquisition of securities at price $ 29.13 per share. | 17 Apr 2023 | 3,260 | 10,654 (0%) | 0% | 29.1 | 94,964 | Common Stock |
| Upstart Holdings Inc | Sanjay Datta | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.18 per share. | 17 Apr 2023 | 3,200 | 448,268 | - | 15.2 | 48,587 | Common Stock |
| Upstart Holdings Inc | Sanjay Datta | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 3,200 | 28,339 | - | - | Employee Stock Option (Right to buy) | |
| Upstart Holdings Inc | Sanjay Datta | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.35 per share. | 17 Apr 2023 | 3,200 | 451,468 | - | 1.4 | 4,320 | Common Stock |
| First Business Fin Services Inc | Mark J. Meloy | EVP | 17 Apr 2023 | 3,180 | 56,538 (0%) | 0% | 29.1 | 92,633 | Common Stock | |
| Cns Pharma Inc | Christopher Downs | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.20 per share. | 17 Apr 2023 | 3,100 | 9,251 (0%) | 0% | 3.2 | 9,920 | Common Stock |
| Trimble | Jennifer K. Lin | Chief Platform Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 3,047 | 6,096 | - | - | Restricted Stock Unit | |
| Trimble | Jennifer K. Lin | Chief Platform Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.78 per share. | 17 Apr 2023 | 3,047 | 3,047 (0%) | 0% | 49.8 | 151,680 | Common Stock |
| LCI Ind | Lillian D. Etzkorn | EVP CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 3,006 | 3,006 | - | - | Restricted Stock Unit | |
| AAR Corp | John M. Holmes | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Apr 2023 | 3,000 | 265,611 (0%) | 0% | 0 | Common Stock | |
| BlackRock | J. Richard Kushel | Senior Managing Director | Sale of securities on an exchange or to another person at price $ 696.00 per share. | 17 Apr 2023 | 3,000 | 71,307 (0%) | 0% | 696.0 | 2,087,993 | Shares Of Common Stock (par Value $0.01 Per Share) |
| Chord Energy Corp - Ordinary Shares - New | Lynn A. Peterson | Director | Sale of securities on an exchange or to another person at price $ 144.94 per share. | 17 Apr 2023 | 3,000 | 238,098 | - | 144.9 | 434,820 | Common Stock |
| Boston Scientific | Wendy Carruthers | EVP, Human Resources | 17 Apr 2023 | 2,960 | 23,679 | - | - | Stock Option (Right to Buy) | ||
| Boston Scientific | Wendy Carruthers | EVP, Human Resources | 17 Apr 2023 | 2,960 | 95,044 (0%) | 0% | 13.1 | 38,717 | Common Stock | |
| Trimble | Peter Large | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 2,926 | 5,852 | - | - | Restricted Stock Unit | |
| Trimble | Peter Large | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.78 per share. | 17 Apr 2023 | 2,926 | 3,079 (0%) | 0% | 49.8 | 145,656 | Common Stock |
| First Business Fin Services Inc | Daniel S. Ovokaitys | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 29.13 per share. | 17 Apr 2023 | 2,890 | 12,312 (0%) | 0% | 29.1 | 84,186 | Common Stock |
| DexCom | Paul R. Flynn | EVP Global Revenue | Sale of securities on an exchange or to another person at price $ 120.00 per share. | 17 Apr 2023 | 2,781 | 52,112 (0%) | 0% | 120 | 333,720 | Common Stock |
| First Business Fin Services Inc | Barbara M. Conley | General Counsel | Grant, award, or other acquisition of securities at price $ 29.13 per share. | 17 Apr 2023 | 2,740 | 29,388 (0%) | 0% | 29.1 | 79,816 | Common Stock |
| SiTime Corp | Lionel Bonnot | See Remarks | Sale of securities on an exchange or to another person at price $ 120.00 per share. | 17 Apr 2023 | 2,693 | 102,115 (0%) | 0% | 120 | 323,160 | Common Stock |
| Trimble | David G. Barnes | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.78 per share. | 17 Apr 2023 | 2,688 | 34,447 (0%) | 0% | 49.8 | 133,809 | Common Stock |
| Arista Networks | Anshul Sadana | SVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 2,664 | 14,668 | - | - | Non-Qualified Stock Option (right to buy) | |
| Arista Networks | Anshul Sadana | SVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 61.05 per share. | 17 Apr 2023 | 2,664 | 102,150 (0%) | 0% | 61.0 | 162,637 | Common Stock |
| Ionis Pharma Inc | Onaiza Cadoret-Manier | EVP, Chf GL Pdt Str & Oper Ofc | Sale of securities on an exchange or to another person at price $ 36.50 per share. | 17 Apr 2023 | 2,582 | 24,312 (0%) | 0% | 36.5 | 94,250 | Common Stock |
| Lakeland Ind Inc | Christopher J. Ryan | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.55 per share. | 17 Apr 2023 | 2,569 | 123,346 (1%) | 0% | 12.6 | 32,241 | Common Stock, par value $.01 per share |
| CIENA Corp | Scott McFeely | SVP, Networking Platforms | Sale of securities on an exchange or to another person at price $ 50.77 per share. | 17 Apr 2023 | 2,500 | 100,230 (0%) | 0% | 50.8 | 126,925 | Common Stock |
| AerSale Corp | Andrew C. Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 2,486 | 2,486 | - | 0 | Common Stock | |
| First Business Fin Services Inc | Jodi A. Chandler | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 29.13 per share. | 17 Apr 2023 | 2,460 | 26,839 (0%) | 0% | 29.1 | 71,660 | Common Stock |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 165.32 per share. | 17 Apr 2023 | 2,448 | 446,134 (0%) | 0% | 165.3 | 404,711 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 165.32 per share. | 17 Apr 2023 | 2,448 | 441,586 (0%) | 0% | 165.3 | 404,711 | Class A Common Stock |
| FactSet Research | Goran Skoko | EVP, Research & Advisory | Sale of securities on an exchange or to another person at price $ 413.64 per share. | 17 Apr 2023 | 2,400 | 4,352 (0%) | 0% | 413.6 | 992,736 | Common Stock |
| SBA Communications (Class A) | Kevin L. Beebe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 100.00 per share. | 17 Apr 2023 | 2,308 | 16,635 (0%) | 0% | 100 | 230,800 | Class A Common Stock |
| SBA Communications (Class A) | Kevin L. Beebe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 2,308 | 0 | - | - | Stock Options (Right to Buy) | |
| ProFrac Holding Corp (Class A) | Matthew A Greenwood | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 2,132 | 81,317 | - | 0 | Class A common stock, par value $0.01 per share | |
| Lantheus Holdings Inc | Etienne Montagut | Chief Business Officer | 17 Apr 2023 | 2,118 | 67,254 (0%) | 0% | 88.7 | 187,803 | Common Stock | |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.01 per share. | 17 Apr 2023 | 2,092 | 204,069 | - | 18.0 | 37,675 | Common Stock |
| Trade Desk Inc (Class A) | David Randall Pickles | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.00 per share. | 17 Apr 2023 | 2,020 | 472,950 (1%) | 0% | 30.0 | 60,602 | Class A Common Stock |
| Trade Desk Inc (Class A) | David Randall Pickles | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 2,020 | 26,310 | - | - | Employee Stock Option (Right to buy) | |
| Trade Desk Inc (Class A) | David Randall Pickles | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 60.70 per share. | 17 Apr 2023 | 2,020 | 470,930 (1%) | 0% | 60.7 | 122,614 | Class A Common Stock |
| GDL Fund | Mario J. Gabelli | Director, Ten Percent Owner, Control Person of Adviser | Sale of securities on an exchange or to another person at price $ 7.85 per share. | 17 Apr 2023 | 2,000 | 48,000 (0%) | 0% | 7.9 | 15,700 | Common Shares, Par Value $0.001 |
| Roblox Corp (Class A) | Craig Donato | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 40.25 per share. | 17 Apr 2023 | 2,000 | 1,248,097 | - | 40.3 | 80,500 | Class A Common Stock |
| Taylor Morrison Home Corp | William H. Lyon | Director | Sale of securities on an exchange or to another person at price $ 38.52 per share. | 17 Apr 2023 | 2,000 | 153,570 (0%) | 0% | 38.5 | 77,040 | Common Stock |
| Backblaze Inc (Class A) | Gleb Budman | Director, CEO and Chairperson, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.50 per share. | 17 Apr 2023 | 2,000 | 93,128 | - | 4.5 | 9,000 | Class A Common Stock |
| Backblaze Inc (Class A) | Gleb Budman | Director, CEO and Chairperson, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.70 per share. | 17 Apr 2023 | 2,000 | 97,128 | - | 4.7 | 9,400 | Class A Common Stock |
| Backblaze Inc (Class A) | Gleb Budman | Director, CEO and Chairperson, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.58 per share. | 17 Apr 2023 | 2,000 | 95,128 | - | 4.6 | 9,160 | Class A Common Stock |
| Backblaze Inc (Class A) | Tim Nufire | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.59 per share. | 17 Apr 2023 | 2,000 | 1,092,000 | - | 4.6 | 9,180 | Class A Common Stock |
| Backblaze Inc (Class A) | Tim Nufire | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.50 per share. | 17 Apr 2023 | 2,000 | 1,090,000 | - | 4.5 | 9,000 | Class A Common Stock |
| Backblaze Inc (Class A) | Tim Nufire | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.70 per share. | 17 Apr 2023 | 2,000 | 1,094,000 | - | 4.7 | 9,400 | Class A Common Stock |
| 8X8 Inc | Samuel Wilson | Interim Chief Executive Off. | Sale of securities on an exchange or to another person at price $ 3.73 per share. | 17 Apr 2023 | 2,000 | 748,308 (0%) | 0% | 3.7 | 7,463 | Common Stock |
| Nuvalent Inc (Class A) | Deborah Miller | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 17 Apr 2023 | 2,000 | 2,000 | - | 6.9 | 13,780 | Class A Common Stock |
| Nuvalent Inc (Class A) | Deborah Miller | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 2,000 | 213,170 | - | - | Stock Option (Right to Buy) | |
| Otter Tail Corp | Nathan I. Partain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 2,000 | 9,209 (0%) | 0% | - | Common Stock | |
| Pulse Biosciences Inc | Mitchell E. Levinson | Director, Chief Strategy Officer | 17 Apr 2023 | 2,000 | 2,000 | - | - | Stock Option (right to buy) | ||
| Vivani Medical Inc | Alexandra Larson | Director | Grant, award, or other acquisition of securities at price $ 1.05 per share. | 17 Apr 2023 | 1,967 | 2,166 | - | 1.0 | 2,065 | Common Stock |
| Lantheus Holdings Inc | Daniel M. Niedzwiecki | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 1,960 | 1,960 | - | - | Stock Option (right to buy) | |
| Lakeland Ind Inc | Jeffrey T. Schlarbaum | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.55 per share. | 17 Apr 2023 | 1,957 | 15,700 (0%) | 0% | 12.5 | 24,560 | Common Stock, par value $.01 per share |
| Lakeland Ind Inc | James M. Jenkins | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.55 per share. | 17 Apr 2023 | 1,957 | 17,881 (0%) | 0% | 12.5 | 24,560 | Common Stock, par value $.01 per share |
| Otter Tail Corp | Karen M. Bohn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 1,900 | 45,850 (0%) | 0% | - | Common Stock | |
| Otter Tail Corp | Steven L. Fritze | Director | 17 Apr 2023 | 1,900 | 27,133 (0%) | 0% | - | Common Stock | ||
| Otter Tail Corp | Thomas J. Webb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 1,900 | 12,700 (0%) | 0% | - | Common Stock | |
| Otter Tail Corp | Kathryn O. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 1,900 | 24,553 (0%) | 0% | - | Common Stock | |
| Otter Tail Corp | Michael E. LeBeau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 1,900 | 4,400 (0%) | 0% | - | Common Stock | |
| Otter Tail Corp | Jeanne H. Crain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 1,900 | 1,900 (0%) | 0% | - | Common Stock | |
| Otter Tail Corp | Mary Ludford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 1,900 | 1,900 (0%) | 0% | - | Common Stock | |
| Nuvalent Inc (Class A) | Deborah Miller | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 30.15 per share. | 17 Apr 2023 | 1,875 | 0 | - | 30.1 | 56,531 | Class A Common Stock |
| Ionis Pharma Inc | Brian Birchler | EVP, Corp and Development Ops | 17 Apr 2023 | 1,875 | 27,720 | - | - | Restricted Stock Unit | ||
| Ionis Pharma Inc | Brian Birchler | EVP, Corp and Development Ops | 17 Apr 2023 | 1,875 | 37,200 (0%) | 0% | 0 | Common Stock | ||
| Agilon Health Inc | Benjamin Shaker | Chief Markets Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 1,851 | 0 | - | - | Options (Right to buy) | |
| Agilon Health Inc | Benjamin Shaker | Chief Markets Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 17 Apr 2023 | 1,851 | 81,394 | - | 1 | 1,851 | Common Stock |
| Conoco Phillips | Caroline Maury Devine | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 1,849 | 20,056 | - | - | Stock Units | |
| Conoco Phillips | Caroline Maury Devine | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 1,849 | 1,849 (0%) | 0% | - | Common Stock | |
| Conoco Phillips | Sharmila N. Shahani | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 1,849 | 1,849 (0%) | 0% | - | Common Stock | |
| Conoco Phillips | Sharmila N. Shahani | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 1,849 | 20,056 | - | - | Stock Units | |
| Conoco Phillips | Jody Freeman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 1,849 | 25,284 | - | - | Stock Units | |
| Conoco Phillips | Jody Freeman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 1,849 | 6,680 (0%) | 0% | - | Common Stock | |
| Lakeland Ind Inc | An Hui | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.55 per share. | 17 Apr 2023 | 1,825 | 34,400 (0%) | 0% | 12.6 | 22,904 | Common Stock, par value $.01 per share |
| MKS Instruments Inc | Mark Milton Gitin | EVP & GM, PSD | 17 Apr 2023 | 1,797 | 12,190 (0%) | 0% | - | Common Stock | ||
| MKS Instruments Inc | Mark Milton Gitin | EVP & GM, PSD | 17 Apr 2023 | 1,797 | 9,081 | - | - | Restricted Stock Unit | ||
| Fennec Pharma Inc | Chris A. Rallis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. | 17 Apr 2023 | 1,700 | 33,777 (0%) | 0% | 2.9 | 4,998 | Common Shares |
| First Business Fin Services Inc | David R. Seiler | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.13 per share. | 17 Apr 2023 | 1,690 | 24,884 (0%) | 0% | 29.1 | 49,230 | Common Stock |
| Otter Tail Corp | John D. Erickson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 1,600 | 3,400 (0%) | 0% | - | Common Stock | |
| Transdigm Group | Walter Nicholas Howley | Director | Sale of securities on an exchange or to another person at price $ 753.49 per share. | 17 Apr 2023 | 1,510 | 23,993 (0%) | 0% | 753.5 | 1,137,771 | Common Stock |
| ResMed | Robert Andrew Douglas | President and COO | Sale of securities on an exchange or to another person at price $ 224.65 per share. | 17 Apr 2023 | 1,500 | 256,526 (0%) | 0% | 224.7 | 336,975 | ResMed Common Stock |
| Lakeland Ind Inc | Alfred John Kreft | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.55 per share. | 17 Apr 2023 | 1,468 | 57,499 (0%) | 0% | 12.5 | 18,423 | Common Stock, par value $.01 per share |
| Trimble | Jennifer Allison | Corporate VP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 1,462 | 2,926 | - | - | Restricted Stock Unit | |
| Trimble | Jennifer Allison | Corporate VP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.78 per share. | 17 Apr 2023 | 1,462 | 6,626 (0%) | 0% | 49.8 | 72,778 | Common Stock |
| Arcturus Therapeutics Holdings Inc | Keith C. Kummerfeld | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 1,437 | 8,563 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Holdings Inc | Keith C. Kummerfeld | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.99 per share. | 17 Apr 2023 | 1,437 | 7,918 (0%) | 0% | 5.0 | 7,171 | Common Stock |
| Agilon Health Inc | Benjamin Shaker | Chief Markets Officer | Sale of securities on an exchange or to another person at price $ 28.54 per share. | 17 Apr 2023 | 1,400 | 79,543 | - | 28.5 | 39,957 | Common Stock |
| Stanley Black & Decker | Graham N. Robinson | SVP & President of Industrial | 17 Apr 2023 | 1,393 | 28,596 (0%) | 0% | 79.4 | 110,559 | Common Stock | |
| Glaukos Corp | Thomas W. Burns | Director, CHAIRMAN & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.69 per share. | 17 Apr 2023 | 1,292 | 674,480 (1%) | 0% | 48.7 | 62,907 | Common Stock |
| Zurn Elkay Water Soln Corp | George C. Moore | Director | Grant, award, or other acquisition of securities at price $ 20.90 per share. | 17 Apr 2023 | 1,256 | 76,353 (0%) | 0% | 20.9 | 26,250 | Common Stock |
| Trimble | Darryl R. Matthews | SVP & Sector Head | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.78 per share. | 17 Apr 2023 | 1,255 | 42,880 (0%) | 0% | 49.8 | 62,474 | Common Stock |
| Trimble | Ronald J. Bisio | Sr. Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.78 per share. | 17 Apr 2023 | 1,255 | 62,870 (0%) | 0% | 49.8 | 62,474 | Common Stock |
| Transdigm Group | Walter Nicholas Howley | Director | Sale of securities on an exchange or to another person at price $ 754.43 per share. | 17 Apr 2023 | 1,250 | 22,743 (0%) | 0% | 754.4 | 943,034 | Common Stock |
| Brandywine Realty Trust | Shawn Neuman | General Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.05 per share. | 17 Apr 2023 | 1,248 | 44,414 (0%) | 0% | 4.0 | 5,054 | Common Shares of Beneficial Interest |
| Zurn Elkay Water Soln Corp | Thomas D. Christopoul | Director | Grant, award, or other acquisition of securities at price $ 20.90 per share. | 17 Apr 2023 | 1,227 | 96,682 (0%) | 0% | 20.9 | 25,644 | Common Stock |
| Flex Ltd | Lay Koon Tan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 1,214 | 233,280 (0%) | 0% | 0 | Ordinary Shares | |
| Flex Ltd | Michael E. Hurlston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 1,214 | 49,534 (0%) | 0% | 0 | Ordinary Shares | |
| Zurn Elkay Water Soln Corp | Peggy Troy | Director | Grant, award, or other acquisition of securities at price $ 20.90 per share. | 17 Apr 2023 | 1,197 | 44,355 (0%) | 0% | 20.9 | 25,017 | Common Stock |
| Zurn Elkay Water Soln Corp | David C. Longren | Director | Grant, award, or other acquisition of securities at price $ 20.90 per share. | 17 Apr 2023 | 1,137 | 77,625 (0%) | 0% | 20.9 | 23,763 | Common Stock |
| Trimble | Julie A. Shepard | Vice President Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 1,097 | 2,195 | - | - | Restricted Stock Unit | |
| Trimble | Julie A. Shepard | Vice President Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.78 per share. | 17 Apr 2023 | 1,097 | 44,106 (0%) | 0% | 49.8 | 54,609 | Common Stock |
| Zurn Elkay Water Soln Corp | Rosemary M. Schooler | Director | Grant, award, or other acquisition of securities at price $ 20.90 per share. | 17 Apr 2023 | 1,077 | 42,148 (0%) | 0% | 20.9 | 22,509 | Common Stock |
| Trimble | Peter Large | Senior Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.78 per share. | 17 Apr 2023 | 1,076 | 2,003 (0%) | 0% | 49.8 | 53,563 | Common Stock |
| Trimble | Jennifer K. Lin | Chief Platform Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.78 per share. | 17 Apr 2023 | 1,054 | 1,993 (0%) | 0% | 49.8 | 52,468 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 85.55 per share. | 17 Apr 2023 | 1,050 | 1,733,288 (10%) | 0% | 85.5 | 89,826 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 85.55 per share. | 17 Apr 2023 | 1,050 | 1,676,213 (9%) | 0% | 85.5 | 89,826 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 85.55 per share. | 17 Apr 2023 | 1,050 | 1,673,156 (9%) | 0% | 85.5 | 89,826 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 85.55 per share. | 17 Apr 2023 | 1,050 | 1,737,638 (10%) | 0% | 85.5 | 89,826 | Common Stock |
| First Business Fin Services Inc | Bradley A. Quade | Chief Credit Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.13 per share. | 17 Apr 2023 | 1,044 | 9,610 (0%) | 0% | 29.1 | 30,412 | Common Stock |
| Arista Networks | Anshul Sadana | SVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 164.41 per share. | 17 Apr 2023 | 1,038 | 72,460 (0%) | 0% | 164.4 | 170,660 | Common Stock |
| Bread Fin Holdings Inc | John C. Gerspach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 1,038 | 26,168 (0%) | 0% | - | Common Stock | |
| Arcturus Therapeutics Holdings Inc | Keith C. Kummerfeld | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.12 per share. | 17 Apr 2023 | 1,031 | 1,981 (0%) | 0% | 14.1 | 14,558 | Common Stock |
| Arcturus Therapeutics Holdings Inc | Keith C. Kummerfeld | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 1,031 | 8,969 | - | - | Employee Stock Option (right to buy) | |
| First Business Fin Services Inc | Barbara M. Conley | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.13 per share. | 17 Apr 2023 | 1,024 | 28,364 (0%) | 0% | 29.1 | 29,829 | Common Stock |
| First Business Fin Services Inc | Mark J. Meloy | EVP | 17 Apr 2023 | 1,018 | 55,520 (0%) | 0% | 29.1 | 29,654 | Common Stock | |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 163.28 per share. | 17 Apr 2023 | 1,003 | 445,106 (0%) | 0% | 163.3 | 163,765 | Class A Common Stock |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 163.27 per share. | 17 Apr 2023 | 1,002 | 448,582 (0%) | 0% | 163.3 | 163,601 | Class A Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.